【レポートの概要（一部）】
Table of Contents
Table of Contents 2
List of Tables 6
List of Figures 7
Introduction 8
Global Markets Direct Report Coverage 8
Amyloidosis Overview 9
Therapeutics Development 10
Pipeline Products for Amyloidosis – Overview 10
Pipeline Products for Amyloidosis – Comparative Analysis 11
Amyloidosis – Therapeutics under Development by Companies 12
Amyloidosis – Therapeutics under Investigation by Universities/Institutes 14
Amyloidosis – Pipeline Products Glance 15
Late Stage Products 15
Clinical Stage Products 16
Early Stage Products 17
Amyloidosis – Products under Development by Companies 18
Amyloidosis – Products under Investigation by Universities/Institutes 20
Amyloidosis – Companies Involved in Therapeutics Development 21
Alnylam Pharmaceuticals, Inc. 21
Arcturus Therapeutics, Inc 23
Auven Therapeutics Management L.L.L.P 24
Bellus Health Inc. 25
Bsim2 26
Celgene Corporation 27
GlaxoSmithKline plc 28
Immune System Therapeutics Ltd. 29
Isis Pharmaceuticals, Inc. 30
NeuroPhage Pharmaceuticals, Inc. 31
Onyx Pharmaceuticals, Inc. 32
Pfizer Inc. 33
ProteoTech, Inc. 34
Prothena Corporation plc 35
SOM Innovation Biotech SL 36
Takeda Oncology 37
Amyloidosis – Therapeutics Assessment 38
Assessment by Monotherapy Products 38
Assessment by Combination Products 39
Assessment by Target 40
Assessment by Mechanism of Action 42
Assessment by Route of Administration 44
Assessment by Molecule Type 46
Drug Profiles 48
ALN-TTRsc – Drug Profile 48
Product Description 48
Mechanism of Action 48
R&D Progress 48
ALNTTR-01 – Drug Profile 50
Product Description 50
Mechanism of Action 50
R&D Progress 50
Antisense Oligonucleotide for Transthyretin Amyloidosis – Drug Profile 52
Product Description 52
Mechanism of Action 52
R&D Progress 52
carfilzomib – Drug Profile 53
Product Description 53
Mechanism of Action 53
R&D Progress 53
eprodisate disodium – Drug Profile 57
Product Description 57
Mechanism of Action 57
R&D Progress 57
GSK-2315698 – Drug Profile 59
Product Description 59
Mechanism of Action 59
R&D Progress 59
GSK-2315698 + GSK-2398852 – Drug Profile 60
Product Description 60
Mechanism of Action 60
R&D Progress 60
GSK-2398852 – Drug Profile 61
Product Description 61
Mechanism of Action 61
R&D Progress 61
ISIS-TTRRx – Drug Profile 62
Product Description 62
Mechanism of Action 62
R&D Progress 62
IST-1097 – Drug Profile 63
Product Description 63
Mechanism of Action 63
R&D Progress 63
ixazomib citrate – Drug Profile 64
Product Description 64
Mechanism of Action 64
R&D Progress 64
LUNAR-102 – Drug Profile 67
Product Description 67
Mechanism of Action 67
R&D Progress 67
Monoclonal Antibody for Amyloidosis – Drug Profile 68
Product Description 68
Mechanism of Action 68
R&D Progress 68
Monoclonal Antibody to Inhibit ATTR for Familial Amyloid Polyneuropathy – Drug Profile 69
Product Description 69
Mechanism of Action 69
R&D Progress 69
NEOD-001 – Drug Profile 70
Product Description 70
Mechanism of Action 70
R&D Progress 70
NPT-005 – Drug Profile 72
Product Description 72
Mechanism of Action 72
R&D Progress 72
patisiran – Drug Profile 73
Product Description 73
Mechanism of Action 73
R&D Progress 73
pomalidomide – Drug Profile 74
Product Description 74
Mechanism of Action 74
R&D Progress 74
PTI-110 – Drug Profile 78
Product Description 78
Mechanism of Action 78
R&D Progress 78
RNAi Oligonucleotides to Inhibit Amyloid Precursor Protein for Amyloidosis – Drug Profile 79
Product Description 79
Mechanism of Action 79
R&D Progress 79
Small Molecule for AL Amyloidosis – Drug Profile 80
Product Description 80
Mechanism of Action 80
R&D Progress 80
Small Molecules to Inhibit Transthyretin for Familial Amyloid Polyneuropathy – Drug Profile 81
Product Description 81
Mechanism of Action 81
R&D Progress 81
Small Molecules to Inhibit Transthyretin Related Amyloid Protein for Familial Amyloidotic Cardiomyopathy – Drug Profile 82
Product Description 82
Mechanism of Action 82
R&D Progress 82
Small Molecules to Inhibit Transthyretin Related Amyloid Protein for Familial Amyloidotic Polyneuropathy – Drug Profile 83
Product Description 83
Mechanism of Action 83
R&D Progress 83
tafamidis meglumine – Drug Profile 84
Product Description 84
Mechanism of Action 84
R&D Progress 84
tolcapone – Drug Profile 86
Product Description 86
Mechanism of Action 86
R&D Progress 86
Amyloidosis – Recent Pipeline Updates 87
Amyloidosis – Dormant Projects 116
Amyloidosis – Product Development Milestones 117
Featured News & Press Releases 117
Dec 15, 2014: Prothena Receives FDA Fast Track Designation for NEOD001, a Monoclonal Antibody for the Treatment of Patients With AL Amyloidosis 117
Dec 11, 2014: Alnylam Initiates ENDEAVOUR Phase 3 Clinical Trial with Revusiran (ALN-TTRsc), an Investigational RNAi Therapeutic Targeting Transthyretin (TTR) for the Treatment of TTR Cardiac Amyloidosis 118
Dec 11, 2014: Alnylam Initiates ENDEAVOUR Phase 3 Clinical Trial with Revusiran (ALN-TTRsc), an Investigational RNAi Therapeutic Targeting Transthyretin (TTR) for the Treatment of TTR Cardiac Amyloidosis 119
Dec 02, 2014: Prothena Initiates NEOD001 Global Phase 3 Registrational Trial Based on Positive Results in Ongoing Phase 1/2 Study of NEOD001 in Patients With AL Amyloidosis 121
Dec 01, 2014: Takeda’s Investigational, Oral Proteasome Inhibitor Ixazomib Granted Breakthrough Therapy Designation by U.S. FDA for Relapsed or Refractory Systemic Light-chain Amyloidosis 123
Nov 14, 2014: Alnylam Announces Positive Initial Phase 2 Data with Revusiran 124
Nov 05, 2014: Alnylam Completes Phase 2 Enrollment and Initiates Open-Label Extension Study with Revusiran (ALN-TTRsc), an Investigational RNAi Therapeutic Targeting Transthyretin for the Treatment of TTR Cardiac Amyloidosis 126
Oct 14, 2014: Alnylam Presents Additional Data From Phase 1 Trial With ALN-TTRsc At 10th Annual Meeting of the Oligonucleotide Therapeutics Society 128
Oct 13, 2014: Arcturus Therapeutics to Present Gene Knockdown Data in Non-Human Primates, Showing up to 94% Reduction in Gene Expression with a Single Low Dose 129
Oct 13, 2014: Alnylam Reports Six-Month Clinical Data from Patisiran Phase 2 Open-Label Extension (OLE) Study in Patients with Familial Amyloidotic Polyneuropathy (FAP) 129
Appendix 132
Methodology 132
Coverage 132
Secondary Research 132
Primary Research 132
Expert Panel Validation 132
Contact Us 133
Disclaimer 133
【レポート販売概要】
■ タイトル：アミロイドーシス(Amyloidosis)の治療薬パイプライン動向（2015年上半期版）■ 英文：Amyloidosis - Pipeline Review, H1 2015
■ 発行日：2015年1月22日
■ 調査会社：Global Markets Direct
■ 商品コード：GMDHC6041IDB
■ 調査対象地域：グローバル
- パイプ塗装の世界市場予測（～2021年）The global pipe coatings market size, in terms of value, is projected to reach USD 14.42 Billion by 2021, at a CAGR of 4.7% from 2016 to 2021. The high demand is attributed to the growing pipeline industry globally. Also the demand is driven by the growing technological advancements in the pipeline coatings market. Thermoplastic polymer coatings are the most-widely used type of pipe coatings, and …
- Adult Respiratory Distress Syndrome：グローバル臨床試験レビューH2, 2013Adult Respiratory Distress Syndrome Global Clinical Trials Review, H2, 2013 Summary GlobalData's clinical trial report, “Adult Respiratory Distress Syndrome Global Clinical Trials Review, H2, 2013" provides data on the Adult Respiratory Distress Syndrome clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Adult Respiratory Distress Syndro …
- ロボットコントローラの世界市場2016-2020About Robots Robots are critical components in the fourth industrial revolution. The widespread use of industrial robots and robot controllers is expected to reduce the total cost of labor in the manufacturing industry by at least 15% globally by 2025. The output in terms of labor and productivity can improve by a minimum of 20%. The International Federation of Robotics estimates that as many as 1 …
- OTN（光伝達網）装置の世界市場2016-2020About Optical Transport Network Equipment OTN is a set of network elements that are connected using optical fiber links. The network provides data transportation, switching, multiplexing, supervision, management, and monitoring of channels carrying client signals. The network is defined by the ITU's G.709 interface. This interface has made it possible to provide a network-wide framework, adding si …
- IPビデオ監視及びVSaaSの世界市場：ハードウェア、ソフトウェア、クラウドベースソリューション、サービスThe IP video surveillance & VSaaS market is expected to leverage high potential for the commercial and infrastructure industry verticals in 2026. The current business scenario is witnessing an increase in the demand for surveillance systems, particularly in the developing regions such as China, India, and others, due to rise in government mandates related to public safety and security. Companies i …
- 世界の飲料市場インサイト：品質、耽溺、プレミアム化戦略Synopsis Quality, Indulgence, and Premiumization Strategies in Alcohol, Soft Drinks, and Hot Drinks - defending against margin erosion”provides a comprehensive overview and strategic analysis of how brands can effectively defend their profits despite the emergence of value competitors. The report focuses on the strategy of premiumization, to encourage consumers to trade-up in terms of both price a …
- 世界のグラフェン市場：用途別分析The global market for graphene continues to grow, with weekly technology and production breakthroughs, new investment and public listings of graphene producers. Driven by demand from markets where advanced materials are required, graphene promises to outstrip all current nanomaterials, especially in electronics and energy storage applications. Other markets graphene is impacting include aerospace, …
- 世界におけるタッチスクリーン向けのハプティック技術市場The haptic technology has been explored for human computer interaction since long. It became popular and well known in the form of vibrating alarms in cell phones. Haptic sensing is considered to be more direct as compared to the other senses used in human computer interaction like audition and vision. The touch sensations are created by a haptic actuator embedded in the device. Some of the major …
- 非致死性兵器の世界市場2015-2025The non-lethal weapons market is expected to record strong growth rates over the next decade. Non-lethal weapons are becoming a standard piece of equipment for police departments in the developed world as well as starting to see use in the developing world. New developments in technology have made directed energy weapons operationally feasible for the first time. Though recent pressures on defence …
- 核燃料の世界市場ABSTRACTAbout Nuclear Fuels Nuclear fuel is a substance used to initiate and sustain a nuclear fission reaction in nuclear power stations to generate heat. This heat powers turbine to produce usable electrical energy. A nuclear reactor is a structure in which fissile material undergoes a controlled, self-sustaining nuclear reaction with simultaneous release of energy, which can be used to generate …
- 世界の遮断器、ヒューズ、リレー市場：Global Circuit Breaker, Fuse, and Relay Market 2014-2018TechNavio's analysts forecast the Global Circuit Breaker, Fuse, and Relay market to grow at a CAGR of 5.38 percent over the period 2013-2018. One of the key factors contributing to this market growth is the increased construction activities. The Global Circuit Breaker, Fuse, and Relay market has also been witnessing the increasing need for miniaturization. However, the availability of low cost pro …
- ベビー用電子玩具の世界市場2015-2019About Baby Electronic Toys Toys and games are used for the amusement and entertainment of children. Activity toys such as building sets, dolls, puzzles, and card games help children enhance their mental agility, and develop coordination and dexterity. These are considered as recreational items that not only keep the kids engaged, but also train them. Different materials are used to manufacture toy …
- Edta Tetrasodiumの世界市場Edta Tetrasodium (CAS 64-02-8) Market Research Report 2013 presents comprehensive data on edta tetrasodium markets globally and regionally (Europe, Asia, North America etc.) The Edta Tetrasodium (CAS 64-02-8) Market Research Report 2013 includes edta tetrasodium description, covers its application areas and related patterns. It overviews edta tetrasodium market, names edta tetrasodium producers an …
- 金属加工油剤の世界市場2016-2020About Metalworking Fluids Metalworking fluids include a range of oils and other liquids that are used for lubricating or cooling metallic workpieces during industrial procedures such as machining, grinding, forging, stamping, and milling. These fluids reduce friction between the machining or cutting tools and the workpiece, thereby prevent smoking, burning, and damage to the workpiece and equipmen …
- マイクロセグメンテーションの世界市場予測（～2022年）：ネットワークセキュリティ、データベースセキュリティ、アプリケーションセキュリティMarketsandMarkets forecasts the global microsegmentation market size to grow from USD 670.3 Million in 2017 to USD 2,038.7 Million by 2022, at a Compound Annual Growth Rate (CAGR) of 24.9%. The major factors driving the growth of the market are increasing ransomware attacks on connected devices, and increasing usage of security virtualization and cloud computing. Furthermore, the rise in network c …
